• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Over 22% Short Interest - Zynerba Shorts Getting Squeezed Today

September 28, 2017

This morning, Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) announced positive top line results from an open label exploratory CBD-based Phase 2 clinical trial of the company's "FAB-C" drug candidate for the treatment of Fragile X Syndrome Anxiety and Behavioral Challenges. The clinical trial was evaluating ZYNE's ZYN002 cannabidiol, a.k.a. CBD gel in pediatric and adolescent patients with Fragile X syndrome.


A quick look at the most recent short interest data and we see that there are over 3 million shares of ZYNE held short which represents over 22% of ZYNE shares outstanding. Take a look at the chart below and the only word that will come to mind is SQUEEZE!



Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via FacebookTwitterStockTwitsYouTube, and Instagram.



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.